NL-OMON50029尚未招募不适用
FDG-PET/MRI for re-staging of esophageal cancer: a feasibility study - PET/MRI in esophageal cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age *18 years;
- •- Histologically proven esophageal adenocarcinoma or squamous cell carcinoma
- •located caudally to the carina;
- •- Completed neoadjuvant chemoradiotherapy (nCRT);
- •- Scheduled to undergo FDG-PET/CT at 4-6 weeks after nCRT or at 8-12 weeks
- •after nCRT as part of standard clinical care.
排除标准
- •- Contra-indications for MRI (e.g. pacemaker, metal implant, claustrophobia);
- •- Contra-indications for iodinated contrast media (e.g. previous
- •contrast-allergy or eGFR <30 ml/min/1,73m2);
- •- FDG-nonavid tumor as determined from the pre-treatment PET/CT scan;
- •- Incapacitated patients, prohibiting the understanding and giving of informed
- •consent and to complete the questionnaire on experienced burden with PET/MRI.
研究者
相似试验
招募中
不适用
Pet ReInforced by MRI Enhancing detection of Residual Oesophageal cancerocally advanced esophageal adenocarcinoma or squamous cell carcinomaNL-OMON28571Erasmus MC20
已完成
不适用
4D FDG PET-CT imaging in Esophageal cancer10017991Esophageal cancerNL-OMON41189Antoni van Leeuwenhoek Ziekenhuis30
尚未招募
不适用
Prospective Multicenter Observational Study of Esophageal Preservation Survival in definitive Chemoradiotherapy +/- Photodynamic Therapy for Esophageal CancerEsophageal CancerJPRN-UMIN000043767agoya University150
招募中
1 期
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal CancerEsophageal CancerNCT06414902M.D. Anderson Cancer Center60
已完成
不适用
Repeated magnetic resonance imaging in esophageal cancer for adaptive radiation treatment planning during chemoradiotherapy.oesophageal carcinoma1001799010017991esophageal cancerNL-OMON46841niversitair Medisch Centrum Utrecht30